EPRATUZUMAB-CYS-TESIRINE
UNII 7X6143A60Y

Substance Identification & Data

This profile provides standardized clinical and technical data for Epratuzumab-cys-tesirine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 7X6143A60Y.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
7X6143A60Y
CAS Registry Number
N/A
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
EPRATUZUMAB-CYS-TESIRINE
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Epratuzumab-cys-tesirine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

ADC ADCT-602
ANTIBODY-DRUG CONJUGATE ADCT-602
ANTI-CD22/PBD ADC ADCT-602
EPRATUZUMAB TESIRINE
EPRATUZUMAB-CYS-SG3249
EPRATUZUMAB-CYS-TESIRINE
HLL2-CYS-PBD

Technical Codes

ADCT602
ADCT-602
HLL2-TESIRINE